Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 3Phase 1/2 3Phase NA 2Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Letrozole 6Tamoxifen 4Cisplatin 4Anastrozole 4ribociclib 3exemestane 3Vancomycin 3Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Human Papillomavirus Recombinant Vaccine nonavalent 3Dexamethasone 3Carboplatin 3Bevacizumab 3trametinib 2toripalimab 2encorafenib 2dabrafenib 2binimetinib 2atezolizumab 2asciminib 2Vincristine 2Sodium Chloride 2Rituximab 2Prednisone 2Papillomavirus Vaccines 2Methotrexate 2Medroxyprogesterone Acetate 2Lenalidomide 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × HMPL-013 × 90 days × Clear all
NCT06562543 2026-05-20

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Takeda

Phase 4 Recruiting
78 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡